Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.36B$2.36Bderived+7.8% vs Q4 2019 Net Income$50.74M$50.74MderivedN/M vs Q4 2019 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$398,529,000+40.0% Operating Incomederived$95,613,000+557.7% Operating Cash Flowderived$71,027,000+163.3% Free Cash Flowderived$42,281,000+167.9% Margins · derivedGross margin16.9%+3.9 pt vs Q4 2019
Operating margin4.0%+3.4 pt vs Q4 2019
Net margin2.1%+3.9 pt vs Q4 2019
ended Dec 31, 2020 · filed Feb 24, 2021 · 55 d after period end